G. Lu

发表

Identification of a novel compound targeting the nuclear export of influenza A virus nucleoprotein

T. Pan, Junsong Zhang, Hui Zhang, 2017, Journal of cellular and molecular medicine.

Aurora A Kinase Inhibitor AKI603 Induces Cellular Senescence in Chronic Myeloid Leukemia Cells Harboring T315I Mutation

Quentin Liu, Yunting Luo, D. Lin, 2016, Scientific Reports.

Synthesis and biological evaluation of aurora kinases inhibitors based on N-trisubstituted pyrimidine scaffold.

Quentin Liu, Zheng-chao Tu, Yunting Luo, 2018, European journal of medicinal chemistry.

Structure-based drug design: Synthesis and biological evaluation of quinazolin-4-amine derivatives as selective Aurora A kinase inhibitors.

Quentin Liu, Ruibo Wu, Min Yan, 2018, European journal of medicinal chemistry.

Determination of a novel Aurora-A (AurA) kinase AKI603 by UPLC-MS/MS and its application to a bioavailability study in rat.

M. Huang, H. Bi, G. Zhong, 2016, Journal of pharmaceutical and biomedical analysis.

A Novel Aurora Kinase Inhibitor Attenuates Leukemic Cell Proliferation Induced by Mesenchymal Stem Cells

Quentin Liu, Le-Xun Wang, Zi-Jie Long, 2020, Molecular therapy oncolytics.

Qualitative and quantitative analyses of nucleosides and nucleobases in Ganoderma spp. by HPLC-DAD-MS.

K. Leung, Y. Wang, S. P. Li, 2007, Journal of pharmaceutical and biomedical analysis.

Design, Synthesis, and Biological Evaluation of Substituted Pyrimidines as Potential Phosphatidylinositol 3-Kinase (PI3K) Inhibitors.

Yuan Luo, Zheng-chao Tu, Zi-Jie Long, 2016, Journal of medicinal chemistry.

Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors.

Quentin Liu, Zheng-chao Tu, Yunting Luo, 2014, European journal of medicinal chemistry.

Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents.

Quentin Liu, Quentin Liu, Zheng-chao Tu, 2016, European journal of medicinal chemistry.

A novel compound against oncogenic Aurora kinase A overcomes imatinib resistance in chronic myeloid leukemia cells.

Feimeng Zheng, Quentin Liu, Yunting Luo, 2015, International journal of oncology.

A Novel Small Molecule Aurora Kinase Inhibitor Attenuates Breast Tumor–Initiating Cells and Overcomes Drug Resistance

Feimeng Zheng, E. Lam, Quentin Liu, 2014, Molecular Cancer Therapeutics.

Aurora kinase inhibitor restrains STAT5‐activated leukemic cell proliferation by inducing mitochondrial impairment

Quentin Liu, Jin-Xing Wang, Zi-Jie Long, 2020, Journal of cellular physiology.

Structure-based drug design: Synthesis and biological evaluation of quinazolin-4-amine derivatives as selective Aurora A kinase inhibitors.

Quentin Liu, Ruibo Wu, Min Yan, 2018, European journal of medicinal chemistry.

A rapid and sensitive UHPLC–MS/MS method for quantification of 83b1 in plasma and its application to bioavailability study in rats

Xueding Wang, G. Zhong, Jing Guo, 2017, Journal of pharmaceutical and biomedical analysis.